Literature DB >> 2941523

Horizontal and vertical saccadic eye movement abnormalities in Huntington's chorea.

E Bollen, J P Reulen, J C Den Heyer, W Van der Kamp, R A Roos, O J Buruma.   

Abstract

With a newly developed infrared reflection technique, voluntary saccadic eye movements (VOLS), visually evoked saccades (VES) and unsuppressed visually evoked reflex saccades (USVERS) were measured in 11 patients with Huntington's chorea. Abnormalities, including latency increase, peak velocity decrease and undershoot dysmetria with multiple step saccades were found in all types of saccadic eye movements. Peak velocity decrease and undershoot dysmetria can be explained by dysfunction of the brainstem reticular formation in Huntington's chorea. USVERS and square wave jerks occurred abnormally frequently and showed direction-dependent differences. Both were more frequent in horizontal than in vertical direction. Frequency of USVERS and square-wave jerks tended to be correlated. These findings point to disinhibited superior colliculi as a possible common supranuclear origin of USVERS and square-wave jerks in Huntington's chorea.

Entities:  

Mesh:

Year:  1986        PMID: 2941523     DOI: 10.1016/0022-510x(86)90187-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  Reflexive and volitional saccades: biomarkers of Huntington disease severity and progression.

Authors:  Saumil S Patel; Joseph Jankovic; Ashley J Hood; Cameron B Jeter; Anne B Sereno
Journal:  J Neurol Sci       Date:  2011-10-21       Impact factor: 3.181

2.  Eye-head coordination in moderately affected Huntington's Disease patients: do head movements facilitate gaze shifts?

Authors:  W Becker; R Jürgens; J Kassubek; D Ecker; B Kramer; B Landwehrmeyer
Journal:  Exp Brain Res       Date:  2008-09-20       Impact factor: 1.972

3.  Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington's disease.

Authors:  H Heinsen; U Rüb; D Gangnus; G Jungkunz; M Bauer; G Ulmar; B Bethke; M Schüler; F Böcker; W Eisenmenger; M Götz; M Strik
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

4.  Precise recording of eye movement: the IRIS technique. Part 1.

Authors:  J P Reulen; J T Marcus; D Koops; F R de Vries; G Tiesinga; K Boshuizen; J E Bos
Journal:  Med Biol Eng Comput       Date:  1988-01       Impact factor: 2.602

5.  Eye movement especially vertical oculomotor impairment as an aid to assess Parkinson's disease.

Authors:  JianYuan Zhang; Bin Zhang; QingGuo Ren; Qing Zhong; Ye Li; GuoTao Liu; XiaoTian Ma; CuiPing Zhao
Journal:  Neurol Sci       Date:  2020-10-12       Impact factor: 3.307

6.  The use of quantitative oculometry in the assessment of Huntington's disease.

Authors:  F R Ali; A W Michell; R A Barker; R H S Carpenter
Journal:  Exp Brain Res       Date:  2005-11-05       Impact factor: 1.972

7.  Morphological features in juvenile Huntington disease associated with cerebellar atrophy - magnetic resonance imaging morphometric analysis.

Authors:  Abderrahmane Hedjoudje; Gaël Nicolas; Alice Goldenberg; Catherine Vanhulle; Clémentine Dumant-Forrest; Guillaume Deverrière; Pauline Treguier; Isabelle Michelet; Lucie Guyant-Maréchal; Didier Devys; Emmanuel Gerardin; Jean-Nicolas Dacher; Pierre-Hugues Vivier
Journal:  Pediatr Radiol       Date:  2018-06-20

Review 8.  Ocular motor abnormalities in neurodegenerative disorders.

Authors:  C A Antoniades; C Kennard
Journal:  Eye (Lond)       Date:  2014-11-21       Impact factor: 3.775

9.  Square wave jerks in parkinsonian syndromes.

Authors:  O Rascol; U Sabatini; M Simonetta-Moreau; J L Montastruc; A Rascol; M Clanet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-07       Impact factor: 10.154

10.  Oculomotor control in Gilles de la Tourette syndrome.

Authors:  E L Bollen; R A Roos; A P Cohen; R B Minderaa; J P Reulen; B J Van de Wetering; T C Van Woerkom; O J Buruma
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.